Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) EBT Margin (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of EBT Margin data on record, last reported at 27.98% in Q4 2025.

  • For Q4 2025, EBT Margin rose 5642.0% year-over-year to 27.98%; the TTM value through Dec 2025 reached 5.44%, changed N/A, while the annual FY2025 figure was 8.38%, 5999.0% up from the prior year.
  • EBT Margin reached 27.98% in Q4 2025 per CAI's latest filing, up from 180.09% in the prior quarter.
  • Across five years, EBT Margin topped out at 590.06% in Q2 2024 and bottomed at 180.09% in Q3 2025.